Prevalencia de dislipemia y de sus distintos fenotipos en la hipertensión arterial esencial de comienzo reciente

DeFronzo, 1991, Insulin resistance,multifactorial syndrome responsible for NIDDM,obesity, hypertension, dislipidemia, and atherosclerotic cardiovascular syndrome, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173 Castelli, 1986, A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham study, Am J Med, 80, 23, 10.1016/0002-9343(86)90157-9 Rubenstein, 1986, Dyslipoproteinemias and manifestations of coronary heart disease.The Lipid Research Clinics Program Prevalence Study, Circulation, 73, 91 Genest, 1992, Familial lipoprotein disorders in patients with premature coronary artery disease, Circulation, 85, 2025, 10.1161/01.CIR.85.6.2025 Kwiterovich, 1993, Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged = 50 years) and women (= 60 years) with coronary artery disease, Am J Cardiol, 71, 631, 10.1016/0002-9149(93)91002-Y 1999 Kwiterovich, 1988, HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoprotein and associated with coronary artery disease, Clin Chem, 34, B71 Scanu, 1991, Update on lipoprotein(a), Curr Opin Lipidol, 2, 253, 10.1097/00041433-199108000-00006 Wong, 1997, Hemodynamics patterns of age-related changes in blood pressure. The Framingham Heart Study, Circulation, 96, 308, 10.1161/01.CIR.96.1.308 Álvarez de Sotomayor, 1999, Effects of treatment with Simvastatin on endotelial dysfunction in spontaneously hypertensive rats, J Hypertens, 17, 769, 10.1097/00004872-199917060-00008